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Abstract 39	
A mosaic of cross-phyla chemical interactions occurs between all metazoans and their 40	
microbiomes. In humans, the gut harbors the heaviest microbial load, but many organs, 41	
particularly those with a mucosal surface, associate with highly adapted and evolved 42	
microbial consortia1. The microbial residents within these organ systems are increasingly well 43	
characterized, yielding a good understanding of human microbiome composition, but we have 44	
yet to elucidate the full chemical impact the microbiome exerts on an animal and the breadth 45	
of the chemical diversity it contributes2. A number of molecular families are known to be 46	
shaped by the microbiome including short-chain fatty acids, indoles, aromatic amino acid 47	
metabolites, complex polysaccharides, and host lipids; such as sphingolipids and bile acids3–48	
11. These metabolites profoundly affect host physiology and are being explored for their roles 49	
in both health and disease. Considering the diversity of the human microbiome, numbering 50	
over 40,000 operational taxonomic units12, a plethora of molecular diversity remains to be 51	
discovered. Here, we use unique mass spectrometry informatics approaches and data 52	
mapping onto a murine 3D-model13–15 to provide an untargeted assessment of the chemical 53	
diversity between germ-free (GF) and colonized mice (specific-pathogen free, SPF), and 54	
report the finding of novel bile acids produced by the microbiome in both mice and humans 55	
that have evaded characterization despite 170 years of research on bile acid chemistry16. 56	
 57	
Main 58	
        In total, 96 sample sites, covering 29 organs, producing 768 samples (excluding 59	
controls, Fig. S1) were analyzed from four GF and four colonized mice by LC-MS/MS mass 60	
spectrometry and 16S rRNA gene sequencing. The metabolome data was most strongly 61	
influenced by organ source, but as expected, the microbiome was dictated by colonization 62	
status (Fig. 1a,b). GF mice and sterile organs in SPF mice clustered tightly with background 63	
sequence reads from blanks (reflecting their sterility), whereas colonized organs within the 64	
SPF mice clustered apart from these samples (Fig. 1a,b). Mapping the principle coordinate 65	
values of the two data types onto the murine 3-D model showed how the gut samples were 66	
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similar, but important differences were observed, including separation of the stool sample 67	
from the upper GI tract in the metabolome but not in the microbiome, and similarity between 68	
the esophageal and gut microbiomes. The strongest separation in the metabolome between 69	
colonization states was present in the stool, cecum, other regions of the GI tract, and 70	
samples from the surface of the animals including ears and feet (Fig. 1c). The liver also had 71	
signatures suggestive of metabolomic differences between the GF and SPF mice, but these 72	
were not significant compared to the within individual variation (Fig. 1, Fig. S2).  73	
Molecular networking is a novel spectral alignment algorithm that enables identification 74	
of unique molecules in mass spectrometry data and the relationships between related 75	
spectra14. Applying molecular networking to this comprehensive murine dataset identified 76	
7,913 unique spectra (representing putative molecules) of which 14.7% were exclusively 77	
observed in colonized mice and 10.0% were exclusive to GF (Fig. 2). Although the overall 78	
profiles exhibited the strongest difference in the GI tract, molecular networking showed that 79	
all organs had some unique molecular signatures from the microbiome, ranging from 2% in 80	
the bladder to 44% in stool (Fig. 2). As expected, the metabolome of the cecum, site of 81	
microbial fermentation of food products, was profoundly affected by the microbiota, but other 82	
GI sites had weaker signatures. Spectral library searching enabled annotation of 8.86% of 83	
nodes in the molecular network (n=700 annotated nodes13,17); which included members of the 84	
molecular families of plant products, such as soyasaponins and isoflavonoids (sourced from 85	
the soybean (Glycine max, f. Fabaceae) component of mouse chow), host lipids and 86	
microbial metabolic products (Fig. 2a). Many of the unique signatures attributed to the 87	
microbiome were the result of metabolism of plant triterpenoids and flavonoids from food 88	
(Supplemental Data, Fig. S3, S4). These effects were location specific, indicating that the 89	
microbiome inhabits spatially distinct and varied niche space throughout an organism, 90	
exerting location-dependent effects on host physiology through the metabolism of xenobiotics 91	
and modification of host molecules.  92	
The strong impacts from the microbiome in the gastrointestinal (GI) tract led to deeper 93	
analysis of the molecular changes in this organ system. A random forests classification was 94	
used to identify the most differentially abundant molecules between the GF and SPF GI 95	
tracts. The metabolome of both the GF and SPF mice changed through the different sections 96	
of the digestive system (Fig. 3a). While changes through the upper GI tract were subtle in GF 97	
mice, SPF animals had progressive transitions in this region (Fig. 3a). A major transition 98	
occurred between the ileum and cecum in both groups, but the specific molecules that were 99	
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/654756doi: bioRxiv preprint first posted online Jun. 3, 2019; 
	 4	
changing were different between them (Fig. 3a). Many unique metabolites in SPF mice were 100	
unknown compounds, but known molecules were also identified including bile acids and 101	
soyasaponins (Fig. 3a, Supplementary Data, Fig. S3,S5). The Shannon diversity index of the 102	
GF and SPF mouse metabolome was mirrored in the upper GI tract, both being low in the 103	
esophagus and higher in the stomach and duodenum, however, upon transition to the cecum, 104	
the diversity of the two groups of mice began to separate (Fig. 3c,d). The molecular diversity 105	
in the cecum and colon of colonized mice was significantly higher than GF mice (Mann-106	
Whitney U-test), but not in the stool samples (Fig. 3c). 107	
We also compared the changing microbial community through the GI tract in the 108	
context of the changes observed in the molecular data. Similar to the metabolites, 109	
microbiome transitions were observed traversing the GI tract (Fig. 3b). The corresponding 110	
microbial diversity of the colonized animals showed a similar profile to the metabolome, 111	
mostly stable through the upper parts of the system and then abruptly increasing at the 112	
cecum, followed by a decrease in the colon and stool (Fig. 3d). However, an interesting 113	
contrast was observed where a high diversity of the metabolome in the duodenum 114	
corresponded to a lower microbial diversity. We hypothesize that this contrasting result was 115	
due to the secretion of bile acids from the gallbladder at this location. Because these 116	
molecules possess antimicrobial properties, their high abundance may explain the lower 117	
microbial diversity in the upper GI tract18, while simultaneously, microbial modification of the 118	
molecules increases their molecular diversity. After the duodenum, changes in the diversity of 119	
microbiome and metabolome were closely aligned, but colonized mice had greater molecular 120	
diversity in the cecum and colon. This shows that microbial activity in these organs was 121	
altering the molecules present, particularly bile acids, soyasaponins, flavonoids, and other 122	
unknown compounds, which expanded the metabolomic diversity of the cecum 123	
(supplementary results). 124	
Molecular networking also enabled meta-mass shift chemical profiling19 of the GF and 125	
SPF GI tract, which is an analysis of chemical transformations based on parent mass shifts 126	
between related nodes without the requirement of knowing the molecular structure. For 127	
example, a unique node found in colonized mice with an 18.015 Da difference represents 128	
H2O and 2.016 Da is H2. In colonized animals, there was a strong signature for the loss of 129	
water in the duodenum and jejunum and the loss of H2, acetyl and methyl groups in latter 130	
parts of the GI tract (Fig. 3e,f). GF mice had notable mass gains corresponding to 131	
monosaccharides in all regions of the GI tract, which were absent in SPF animals. Instead, a 132	
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mass gain of C4H8 was seen in the jejunum and ileum of SPF mice, which was associated 133	
with the conjugated bile acid glycocholic acid (Fig. 3e,f). A significant portion of the 134	
dehydrogenation and dehydroxylation mass shifts from the microbiome were associated with 135	
bile acids, indicating that microbial enzymes acted on C-C double bonds of the cholic acid 136	
backbone and removed hydroxyl groups, which is a known microbial transformation3. 137	
Deacetylations were also prevalent in SPF animals, though the metabolites upon which these 138	
losses were occurring remain mostly unidentified. Overall, both GF and SPF mice had many 139	
cases of mass loss between related molecules, but there were comparably fewer molecules 140	
in the colonized mice that showed gain of a molecular group (Fig. 3f). This indicates that the 141	
microbiome contributes more to the catabolic breakdown of molecules and less to anabolism; 142	
however, one interesting anabolic reaction that was detected was the addition of C4H8 on 143	
glycocholic acid, which we subsequently investigated further. 144	
Glycine and taurine conjugated bile acids were detected in both GF and SPF mice. As 145	
they moved through the GI tract, the conjugated amino acid was removed in SPF mice only, 146	
representing a known microbial transformation (Fig. S5,20). In the bile acid molecular network 147	
that contained taurocholic acid and glycocholic acid there were modified forms of these 148	
compounds that were only present in colonized animals. These nodes were related to the 149	
glycocholic acid through spectral similarity and to the sulfated form (Fig. 4a) and one of them 150	
corresponded to the addition of C4H8 described above. Analysis of the MS/MS spectra of the 151	
three nodes m/z 556.363, m/z 572.358 and m/z 522.379 showed maintenance of the core 152	
cholic acid, but with a fragmentation pattern characteristic of the presence of the amino acids 153	
phenylalanine, tyrosine and leucine through an amide bond at the conjugation site in place of 154	
glycine or taurine (Fig. S6). In the extensive bile acid literature, representing 170 years of bile 155	
acid structural analysis and greater than 42,000 publication records in PubMed, the only 156	
known conjugations of murine (and human) bile acids were those of glycine and taurine16. 157	
Here, we have found a set of unique amino acid conjugations to cholic acid mediated by the 158	
microbiome creating the novel bile acids phenylalanocholic acid, tyrosocholic acid and 159	
leucocholic acid. These structures were validated with synthesized standards using NMR and 160	
mass spectrometry methods (Supplemental methods and Fig. S7, S8, S9, S10, S11). These 161	
uniquely conjugated bile acids were detected in the duodenum, jejunum and ileum of SPF 162	
mice, with phenylalanocholic acid being the most abundant (Fig. 4). In comparison, 163	
glycocholic acid was present in the latter parts of the GI tract (cecum and colon), whereas 164	
taurocholic acid was most abundant in the upper parts of the GI tract (reduced through the 165	
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lower GI tract in SPF mice). The concentration of phenylalanocholic acid in mouse ileal 166	
content from the four mice was 0.59 μM (s.d. 0.21) in the duodenum, 3.0 μM (s.d. 4.43) in the 167	
jejunum and 5.25 μM (s.d. 2.42) in the ileum, with its highest concentration reaching 13.24 168	
μM in a single jejunum sample (Fig. S12). These findings demonstrate that these novel amino 169	
acid conjugates are abundant in the upper GI tract of mice on a normal soy-based diet and 170	
require the microbiota for their production, but were subsequently absorbed, further modified, 171	
or deconjugated again upon travel to the cecum.  172	
Because GNPS is a public repository of mass spectrometry data from a wide variety of 173	
biological systems, we used an analysis feature called “single spectrum search” to search all 174	
739 publically available data sets for the presence of MS/MS spectra matching these 175	
conjugated bile acids (April 27, 2018,13). Spectral matches corresponding to 176	
phenylalanocholic acid, tyrosocholic acid and leucocholic acid were found in 19 other studies 177	
comprising samples from the GI tract of both mice (with at least one conjugate found in 3.2 to 178	
59.4% of all samples, Fig. S13) and humans (in 1.6 to 25.3% of all samples, Fig. S13). In a 179	
crowd-sourced fecal microbiome and metabolome study at least one of these unique bile 180	
acids was found in 1.6% of human fecal samples with tyrosocholic acid being the most 181	
prevalent (n=490, the American Gut Project 21, Fig. 4b). They were found in higher frequency 182	
in fecal samples collected without swabs, including studies of patients with inflammatory 183	
bowel syndrome, cystic fibrosis (CF) and infants (Fig. 4b). Re-analysis of data from a 184	
previously published study of the murine microbiome and liver cancer enabled a comparison 185	
of the abundance of these molecules in mice fed a high-fat-diet (HFD) and treated with 186	
antibiotics22, Fig. 4b). Supporting the role of the microbiome in their production, the 187	
Phe/Tyr/Leu amino acid conjugates were decreased with antibiotic exposure, whereas 188	
glycocholic acid, which is synthesized by host liver enzymes, was not. In contrast, these 189	
microbial bile acids were more abundant in mice fed HFD, with no change observed in the 190	
host conjugated glycocholic acid22. In a separate data set where atherosclerosis-prone mice 191	
were similarly fed a HFD the novel conjugates were also increased over time, but not on 192	
normal chow and the host-conjugated taurocholic acid did not change significantly (Fig. S14). 193	
Finally, exploration into the metadata associated with a public study of a pediatric CF patient 194	
cohort showed that there was a higher prevalence of these compounds in CF patients 195	
compared to healthy controls, particularly those with pancreatic insufficiency (Fig. 4b). 196	
Insufficient production of pancreatic lipase in the CF gut results in the buildup of fat and a 197	
microbial dysbiosis23, which parallels the gut microbial ecosystem in mice fed HFD. 198	
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/654756doi: bioRxiv preprint first posted online Jun. 3, 2019; 
	 7	
The first chemical characterization of a bile acid was in 184824, the first correct 199	
structure of a bile acid related molecule was elucidated in 193225 and bile acid metabolism by 200	
the microbiome has been known since the 1960s26. Since then, microbial alteration of bile 201	
acids has been known to occur through four principal mechanisms: dehydroxylation, 202	
dehydration and epimerization of the cholesterol backbone, and deconjugation of the amino 203	
acids taurine or glycine3,27,28. Here, using a simple experiment with colonized and sterile 204	
mice, we have identified a fifth mechanism of bile acid transformation by the microbiome 205	
mediated by a completely novel mechanism: conjugation of the cholesterol backbone with the 206	
amino acids phenylalanine, leucine and tyrosine. Further research is required to determine 207	
the microbial producers of these compounds and their role in gut microbial ecology, 208	
especially considering the important findings that microbiome based bile acid metabolism can 209	
affect C. difficile infections29 or regulate liver cancer30. The findings reported here show that 210	
all bile acid research to date have overlooked a significant component of the human bile acid 211	
pool produced by the microbiome. 212	
In conclusion, the chemistry of all major organs and organ systems are affected by the 213	
presence of a microbiome. The strongest signatures come from the gut through the 214	
modification of host bile acids and xenobiotics, particularly the breakdown of plant natural 215	
products from food. Addition of chemical groups to host molecules were more rare, but those 216	
that were detected were sourced from a unique alteration of host bile acids by the 217	
microbiome that changes our understanding of human bile after 170 years of research16. As 218	
the connections between us and our microbial symbionts becomes more and more obvious, a 219	
combination of globally untargeted approaches and the development of tools that interlink 220	
these data sets will enable us to identify novel molecules, leading to a better understanding of 221	
the deep connection between our microbiota and our health. 222	
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Figures and Figure Legends 308	
 309	
Figure 1. a) Principal coordinate analysis (PCoA) of microbiome and mass spectrometry data 310	
highlighted by sample source as GF or SPF. b) Same data highlighted by organ source. c) 311	
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Bray-Curtis dissimilarities of the metabolome data collected from murine organs. The 312	
dissimilarities are calculated within individual mice of the same group (GF or SPF, “Within”) or 313	
across the GF and SPF groups (GF-SPF). Organs with multiple samples are pooled, but only 314	
samples collected from exact same location are compared. d) 3-D model of murine organs 315	
mapped with the mean 1st principle coordinate value from the four GF and four SPF mice. 316	
High values across the 1st PC are shown in red and lower values are shown in blue. The PC1 317	
values are from the data in panels a) and b). (Er=ear, Br=brain, Ad=adrenal gland, 318	
Es=esophagus, Tr=trachea, Stm=stomach, Kd=kidney, Mo=mouth, D=duodenum, Ov=ovary, 319	
Co=colon, Stl=stool, Hd=hand, Lg=lung, Lv=liver, J=jejunum, Ce=cecum, Bl-bladder, 320	
Ut=uterus, Cx=cervix, Vg=vagina, Ft=feet) 321	
 322	
 323	
Figure 2. a) Molecular network of LC-MS/MS data with nodes colored by source as GF, SPF, 324	
shared, or detected in blanks. Molecular families with metabolites annotated by spectral 325	
matching in GNPS are listed by a number corresponding to the molecular family. These are 326	
level 2 or 3 annotations according to the metabolomics standards consortium 31. b) 327	
percentage of total nodes from each organ sourced from GF only, SPF only or shared and 328	
the total number of unique nodes from each murine class per organ.  329	
 330	
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 331	
Figure 3. a) Mean normalized abundance of the top 30 most differentially abundant 332	
metabolites between GF and SPF mice. The metabolites are colored according to molecular 333	
family, where bile acids are green and blue, respectively, soyasaponins are pink and 334	
unknown molecules are brown/yellow. Colors corresponding to taurocholic acid (green) and 335	
deoxymuricholic acid (teal) are highlighted for reference. b) Microbiome of the murine GI tract 336	
in SPF mice. Taxa of relevance are color coded according to the legend. c) Mean and 95% 337	
confidence interval of the Shannon-Weiner diversity of the metabolomic data in each GI tract 338	
sample for GF and SPF mice. Statistical significance between metabolome diversity in the 339	
same sample location between GF and SPF mice was tested with the Mann-Whitney U-test 340	
(*=p<0.05). d) Mean Faith’s phylogenetic diversity (with 95% confidence interval) of the 341	
microbiome through the SPF GI tract. e) Results of meta-mass shift chemical profiling 19 342	
showing the relative abundance of the parent mass differences between unique nodes in 343	
either GF or SPF mice to the total. Each mass difference corresponds to the node-to-node 344	
gain or loss of a particular chemical group. f) Counts of the number of mass shifts of the 345	
parent mass differences between nodes showing where the most abundant molecular 346	
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transitions are detected in the murine gut. 347	
 348	
 349	
Figure 4. a) Structures, molecular network, 3D-molecular cartography and abundance 350	
through GI tract of novel microbiome associated bile acids in this murine study. Structures of 351	
the previously known conjugates glycocholic acid, taroursocholic acid and taurocholic acid 352	
are shown for comparison to structures of the newly discovered amino acid conjugates. The 353	
molecular network of these bile acids is shown with mapping to the GF and SPF mice 354	
according to the color legend. An inset highlighting the parent masses and mass differences 355	
between the newly discovered molecules is shown for clarity. 3D-molecular cartography 356	
maps the mean abundance and standard deviations of the mean of the newly discovered 357	
conjugates onto a 3D-rendered model of the murine GI tract and the relative abundances of 358	
the molecules through the GI tract samples compared to the host produced glycocholic acid 359	
and taurocholic acid are also shown. b) Bar plots of the percent of samples positive for the 360	
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novel bile acids from publically available datasets on GNPS. Percent of patients where novel 361	
bile acids were detected from two human studies of cystic fibrosis patients compared to non-362	
CF controls. Comparison of the abundance of novel conjugates in a controlled murine study 363	
previously published where animals fed high fat diet (HFD) or normal chow (NC) were 364	
compared and those treated with antibiotics 22. AGP = American Gut Project 21, IBD = 365	
Inflammatory Bowel Disease, CF = cystic fibrosis, PI = pancreatic insufficient, PS = 366	
pancreatic sufficient. 367	
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